BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23174883)

  • 81. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.
    Moreaux J; Reme T; Leonard W; Veyrune JL; Requirand G; Goldschmidt H; Hose D; Klein B
    Br J Cancer; 2013 Aug; 109(3):676-85. PubMed ID: 23868005
    [TBL] [Abstract][Full Text] [Related]  

  • 82. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.
    Våtsveen TK; Tian E; Kresse SH; Meza-Zepeda LA; Gabrea A; Glebov O; Dai HY; Sundan A; Kuehl WM; Børset M
    Leuk Res; 2009 Dec; 33(12):1670-7. PubMed ID: 19395026
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
    Maxwell CA; Pilarski LM
    Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
    [TBL] [Abstract][Full Text] [Related]  

  • 84. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
    Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
    J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
    Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
    Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cytogenetics and molecular cytogenetics in multiple myeloma.
    Liebisch P; Döhner H
    Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Molecular pathogenesis and a consequent classification of multiple myeloma.
    Bergsagel PL; Kuehl WM
    J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Promiscuity of translocation partners in multiple myeloma.
    Martin LD; Belch AR; Pilarski LM
    J Cell Biochem; 2010 Apr; 109(6):1085-94. PubMed ID: 20127714
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Advances in biology of multiple myeloma: clinical applications.
    Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
    Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
    [TBL] [Abstract][Full Text] [Related]  

  • 93. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
    Fonseca R; Bergsagel PL; Drach J; Shaughnessy J; Gutierrez N; Stewart AK; Morgan G; Van Ness B; Chesi M; Minvielle S; Neri A; Barlogie B; Kuehl WM; Liebisch P; Davies F; Chen-Kiang S; Durie BG; Carrasco R; Sezer O; Reiman T; Pilarski L; Avet-Loiseau H;
    Leukemia; 2009 Dec; 23(12):2210-21. PubMed ID: 19798094
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.